Dr. Clotilde Lagier-Tourenne is Associate Professor of Neurology at the Massachusetts General Hospital and Harvard Medical School. She is a member of the Sean M. Healey & AMG Center for ALS at Mass General, recipient of the Araminta Broch-Healey Endowed Chair in ALS, and associate member at the Broad Institute of MIT and Harvard. She trained as a medical geneticist in France and at Columbia University. After a postdoctoral fellowship with Dr. Cleveland, she became Assistant Professor at UCSD in 2013, and moved to the Massachusetts General Hospital in 2015. Her team investigates the molecular mechanisms driving neurodegeneration in amyotrophic lateral sclerosis, frontotemporal dementia and Huntington’s disease. She has established collaborations with academic and pharmaceutical partners to develop novel approaches to therapy, including RNA-targeting antisense oligonucleotides and immunotherapies for ALS and FTD.